80 likes | 99 Views
The global high throughput process development market is expected to reach USD 415.5 Million in 2021 from USD 162.9 Million in 2015, at a CAGR of 14.4%.
E N D
MarketsandMarkets Presents High Throughput Process Development Market Insights on Scope and Growing Demands 2021 https://www.marketsandmarkets.com/Market-Reports/high-throughput-process- development-market-10249359.html
➢ [152 Pages Report] The global high throughput process development market is expected to reach USD 415.5 Million in 2021 from USD 162.9 Million in 2015, at a CAGR of 14.4% during the forecast period. The base year considered for the study is 2015, and the forecast for the market size is provided for the period between 2016 and 2021. In the current market scenario, there is a growing demand for high throughput process development products. ➢ Growth in the global market is mainly driven by the increasing R&D spending, technological advancements in process biopharmaceutical industry, and growing pressure to lower the cost of manufacturing. However, factors such as the high cost of technology and equipment in this market and lack of adequate infrastructural facilities are restraining the growth of this market to a certain extent. development, growth in the https://www.marketsandmarkets.com/Market-Reports/high-throughput-process- development-market-10249359.html
Early buyers will receive 10% customization on Reports. https://www.marketsandmarkets.com/Market-Reports/high-throughput-process- development-market-10249359.html
➢ The high throughput process development market is segmented on the basis of molecule type, end user, technology, product and service, and region. Based on molecule type, the market is classified into monoclonal antibodies and others (recombinant pro-insulin, polysaccharide Fluorescent Protein (rGFP),fusion proteins,and interferon á-2a).The monoclonal antibodies segment accounted for the largest share of the global market in 2016. The large share of this segment is attributed to the increasing adoption of targeted immunotherapy and rising number of US FDA-cleared therapeutic monoclonal antibodies. ➢ Based on end user, the market is categorized into biopharmaceutical companies, contract research organizations Biopharmaceutical companies accounted for the largest share of the global high throughput process development market in 2016. The contract manufacturing organizations segment, on the other hand, is expected to be the fastest-growing end-user segment of the market during the forecast period. High R&D investments by pharmaceutical and biopharmaceutical companies to accelerate drug manufacturing and increasing pressure from regulatory authorities to lower the cost of production are the major factors driving the growth of the biopharmaceutical manufacturers end-user segment. https://www.marketsandmarkets.com/Market-Reports/high-throughput-process- development-market-10249359.html vaccines, recombinant Green and academic research institutes.
➢ Based on technology, the market is categorized into chromatography, ultraviolet- visible spectroscopy,and others (ELISA,chip electrophoresis,SPR,and qPCR).The chromatography segment accounted for the largest share of the global high throughput process development market in 2016. The chromatography segment is further divided into ion exchange chromatography (AC), multimodal (hydrophobic charge induction chromatography (HCIC) and size exclusion chromatography). The affinity chromatography segment accounted for the largest share of the chromatography high throughput process development in 2016. Owing to the advantages of affinity chromatography over other chromatography such as high selectivity, high flow rate and its capacity for extensive removal of process-related impurities such as host cell proteins,DNA,and cell culture media component are driving the growth of the market. ➢ Major players operating in the high throughput process development market include Danaher (US), GE Healthcare (US), Agilent Technologies (US), Merck Millipore (Germany),andThermo Fisher Scientific (US). ➢ To speak to our analyst for a discussion on the above findings, click Speak to Analyst chromatography chromatography (IEC), and affinity others (MC), https://www.marketsandmarkets.com/Market-Reports/high-throughput-process- development-market-10249359.html
About MarketsandMarkets MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. https://www.marketsandmarkets.com/Market-Reports/high-throughput-process- development-market-10249359.html
Contact Us Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 Email: sales@marketsandmarkets.com Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/ Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets https://www.marketsandmarkets.com/Market-Reports/high-throughput-process- development-market-10249359.html